{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Alpharetta",
      "state": "GA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78851",
      "recalling_firm": "Shionogi Inc.",
      "address_1": "5770 Shiloh Rd",
      "address_2": "N/A",
      "postal_code": "30005-8408",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-0219-2018",
      "product_description": "Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30",
      "product_quantity": "968 bottles",
      "reason_for_recall": "Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules",
      "recall_initiation_date": "20170524",
      "center_classification_date": "20180112",
      "termination_date": "20180228",
      "report_date": "20180124",
      "code_info": "Lot#: 7H66200103G, Exp 12/19"
    }
  ]
}